Drug Index

CAPOTEN

Generic: CAPTOPRIL

Review priority: STANDARD Marketing status: Discontinued

Route: ORAL
Class: General Medications
Safety profile: generic
Latest regulatory update: 01 Aug 2017, 12:00 am (UTC)

Structured Monograph

Approval overview CAPOTEN is listed in Drugs@FDA under application 018343 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CAPTOPRIL Form and strength TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor AARXION ANDA HLDING Submission history Latest submission status date: 2017-08-01 00:00:00. Submission type: SUPPL.